Phase I/II Study of Treatment of Stage IV Breast Cancer with OKT3 x Trastuzumab—Armed Activated T Cells

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical breast cancer 2003-08, Vol.4 (3), p.212-217
Hauptverfasser:	Lum, Lawrence G., Rathore, Ritesh, Cummings, Frank, Colvin, Gerald A., Radie-Keane, Kathy, Maizel, Abby, Quesenberry, Peter J., Elfenbein, Gerald J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Biologic response modifiers Breast Neoplasms - pathology Breast Neoplasms - therapy Cytokines Female HER2/ neugene Humans Immunotherapy Muromonab-CD3 - administration & dosage Muromonab-CD3 - therapeutic use Neoplasm Metastasis Neoplasm Staging Patient Selection Receptor, ErbB-2 - analysis Research Design T-Lymphocytes Trastuzumab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!